Annals of Oncology, 31(8), 1046-1055. Elsevier Ltd. Annals of Oncology, 31, 8, pp. 1046-1055 Annals of Oncology, 31(8), 1046-1055. Oxford University Press Annals of Oncology, 31, 1046-1055 Annals of Oncology, 31(8), 1046-1055. ELSEVIER
Neuro-Oncology, 23(8), 1315-1326. Oxford University Press Neuro-Oncology, 23(8), 1315-1326. OXFORD UNIV PRESS INC Neuro Oncol Neuro-oncology, 23(8), 1315-1326. Oxford University Press van der Meulen, M, Dirven, L, Habets, E J J, Bakunina, K, Smits, M, Achterberg, H C, Seute, T, Cull, G, Schouten, H, Zijlstra, J M, Brandsma, D, Enting, R H, Beijert, M, Taphoorn, M J B, van den Bent, M J, Issa, S, Doorduijn, J K & Bromberg, J E C 2021, ' Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: Results from the HOVON 105/ALLG NHL 24 randomized controlled trial ', Neuro-Oncology, vol. 23, no. 8, pp. 1315-1326 . https://doi.org/10.1093/neuonc/noab021
Cancer Medicine, 8(1), 190-199 Cancer Medicine, 8, 190-199 Cancer Medicine, 8(1), 190-199. John Wiley and Sons Ltd Cancer Medicine, 8(1), 190-199. John Wiley & Sons Ltd. Cancer Medicine Cancer Medicine, 8, 1, pp. 190-199 Cancer medicine, 8(1), 190-199. Wiley Cancer Medicine, 8(1), 190. John Wiley and Sons Ltd Rigter, L S, Schaapveld, M, Janus, C P M, Krol, A D G, van der Maazen, R W M, Roesink, J, Zijlstra, J M, van Imhoff, G W, Poortmans, P M P, Beijert, M, Lugtenburg, P J, Visser, O, Snaebjornsson, P, van Eggermond, A M, Aleman, B M P, van Leeuwen, F E & van Leerdam, M E 2019, ' Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer ', Cancer Medicine, vol. 8, no. 1, pp. 190-199 . https://doi.org/10.1002/cam4.1922
JNCI Journal of the National Cancer Institute Journal of the National Cancer Institute, 113, 6, pp. 760-769 JNCI: Journal of the National Cancer Institute, 113(6), 760-769. OXFORD UNIV PRESS INC Journal of the National Cancer Institute, 113(6), 760-769. Oxford University Press Journal of the National Cancer Institute, 113, 760-769
International journal of radiation oncology, biology, physics, 100(5), 1133-1145. Elsevier Inc. International Journal of Radiation Oncology, Biology, Physics, 100, 5, pp. 1133-1145 Thomas, J, Fermé, C, Noordijk, E M, Morschhauser, F, Girinsky, T, Gaillard, I, Lugtenburg, P J, André, M, Lybeert, M L M, Stamatoullas, A, Beijert, M, Hélias, P, Eghbali, H, Gabarre, J, van der Maazen, R W M, Jaubert, J, Bouabdallah, K, Boulat, O, Roesink, J M, Christian, B, Ong, F, Bordessoule, D, Tertian, G, Gonzalez, H, Vranovsky, A, Quittet, P, Tirelli, U, de Jong, D, Audouin, J, Aleman, B M P & Henry-Amar, M 2018, ' Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors : Results of the EORT-GELA H9-F Intergroup Randomized Trial ', International journal of radiation oncology, biology, physics, vol. 100, no. 5, pp. 1133-1145 . https://doi.org/10.1016/j.ijrobp.2017.10.015 International Journal of Radiation Oncology Biology Physics, 100(5), 1133-1145. Elsevier Inc. International Journal of Radiation Oncology, Biology, Physics, 100, 1133-1145 International Journal of Radiation: Oncology-Biology-Physics, Vol. 100, p. 1133-1145 (2018) International Journal of Radiation Oncology Biology Physics, 100(5), 1133-1145. ELSEVIER SCIENCE INC